Natures Sunshine Products Inc (NATR) Stock Price & Analysis
Natures Sunshine Products Inc (NATR) rose 1.92% to USD 20.14 as of June 10, 2026 at 04:58 UTC, according to Nexqual real-time market data.
NATR last closed at USD 19.76; the session ranged USD 19.83–20.45 on volume of 96,992 shares. Market capitalization is $354.16M, with a 52-week range of USD 12.97–28.14 (NCM). Source: Nexqual, June 10, 2026 at 04:58 UTC.
Key Statistics (as of June 10, 2026 at 04:58 UTC)
| Price | USD 20.14 |
|---|---|
| Change | ▲ 1.92% (up) |
| Previous Close | USD 19.76 |
| Open | USD 19.88 |
| Day Range | USD 19.83 – 20.45 |
| 52-Week Range | USD 12.97 – 28.14 |
| Volume | 96,992 shares |
| Market Cap | $354.16M |
| Exchange | NCM |
Technical Analysis (NATR)
Nexqual's technical model rates NATR "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 04:58 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 17.61 (oversold) |
| vs SMA50 | Below (USD 24.19) |
| MACD | -1.29 (negative) |
Analyst Ratings (NATR)
Wall Street analysts rate NATR "None" based on 2 analysts, with a mean price target of USD 35 (range USD 33–37), per Nexqual as of June 10, 2026 at 04:58 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 2 |
| Mean Target | USD 35 |
| High Target | USD 37 |
| Low Target | USD 33 |
| Buy / Hold / Sell | 2 / 0 / 0 |
Earnings (NATR)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 0.29 |
| Revenue Estimate | $126.17M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.3 vs est 0.21 ▲ beat |
| 2025-12-31 | USD 0.3 vs est 0.19 ▲ beat |
| 2025-09-30 | USD 0.36 vs est 0.16 ▲ beat |
| 2025-06-30 | USD 0.35 vs est 0.16 ▲ beat |
Source: Nexqual, June 10, 2026 at 04:58 UTC.
Financials & Fundamentals (NATR)
| Total Revenue | $489.79M |
|---|---|
| Revenue Growth (YoY) | +8.50% |
| Gross Margin | +72.71% |
| Operating Margin | +7.77% |
| Profit Margin | +4.06% |
| ROE | +12.39% |
| Debt / Equity | 13.44 |
| Current Ratio | 2.5 |
| Total Cash | $87.58M |
| Total Debt | $22.43M |
| Free Cash Flow | $23.18M |
Source: Nexqual, June 10, 2026 at 04:58 UTC.
Financial Health Score (NATR)
Nexqual rates Natures Sunshine Products Inc's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 04:58 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 73%, operating 8% |
| Balance Sheet | Strong — $88M cash vs $22M debt, net cash position |
| Cash Flow | Mixed — FCF $23M, slim 4.8% margin |
| Efficiency | Mixed — ROE 12%, ROA 6.8% |
Ownership (NATR)
| Insider Ownership | +3.07% |
|---|---|
| Institutional Ownership | +88.13% |
| Shares Outstanding | 17.58M |
| Float | 12.68M |
| Short % of Float | +2.67% |
Source: Nexqual, June 10, 2026 at 04:58 UTC.
Leadership (NATR)
Natures Sunshine Products Inc is led by Kenneth G. Romanzi (age 65), CEO & Director, per Nexqual as of June 10, 2026 at 04:58 UTC.
| CEO & Director | Kenneth G. Romanzi (age 65) |
|---|---|
| Executive VP & President of Asia/Pacific (APAC) | Daniel C. Norman (age 51) |
| Chief Technology Officer | John Hnanicek |
| Global Chief Marketing Officer | Kevin Fuller Gregory (age 54) |
| Vice President of Global Human Resources | Jason Roberts |
Major Backers & Investors (NATR)
Notable institutional backers of Natures Sunshine Products Inc include WYNNEFIELD CAPITAL INC, Prescott Group Capital Management, L.L.C., American Century Companies Inc, according to Nexqual as of June 10, 2026 at 04:58 UTC.
Active Investors
| Investor | Stake |
|---|---|
| WYNNEFIELD CAPITAL INC | 14.07% |
| Prescott Group Capital Management, L.L.C. | 10.14% |
| American Century Companies Inc | 6.35% |
| Kennedy Capital Management, LLC | 3.93% |
| Acadian Asset Management. LLC | 3.74% |
| Renaissance Technologies | 3.02% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.92% |
| Vanguard Group | 6.72% |
| Dimensional Fund Advisors | 5.09% |
| Geode Capital | 2.12% |
Source: Nexqual, June 10, 2026 at 04:58 UTC.
From Natures Sunshine Products Inc's Latest SEC 10-K Filing (filed 2026-03-10)
Key Strengths & Strategy (as disclosed to the SEC)
- The FDCA has been amended several times with respect to dietary supplements, including amendments by the Nutrition Labeling and Education Act of 1990 and the Dietary Supplement Health and Education Act of 1994, as amended, and the regulations promulgated thereunder.   FDA regulations relating specifically to foods and dietary supplements for human use are set forth in Title 21 of the Code of Federal Regulations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NAII | Natural Alternatives Internatio | USD 2.51 | ▲ 0.2% |
| NBN | Northeast Bank | USD 124.32 | ▲ 4.22% |
| NKSH | National Bankshares, Inc. | USD 35.7 | ▲ 2.59% |
| NRIM | Northrim BanCorp Inc | USD 25.22 | ▲ 1.69% |
| LCUT | Lifetime Brands, Inc. | USD 9.15 | ▲ 2.69% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:58 UTC. This page is informational and not investment advice.